Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) continues to push the envelope in automotive noise suppression technology with another industry first. By leveraging proprietary material technology and optimized structural design, the company’s new BLM15VM series of automotive-compliant chip ferrite beads deliver wide-band noise suppression of high-frequency (5.9GHz) 5G vehicle-to-everything (5G-V2X) applications that exhibit high impedance. Mass production is scheduled to begi...

ZEDRA, a global specialist provider of Active Wealth, Corporate & Global Expansion, Funds and Pension & Incentives services, today announces the appointment of Dean Blackburn as Chief Executive Officer. Having joined the business as Deputy Chief Executive Officer in September 2024, Dean has a proven track record in inspiring and motivating teams - fostering a culture of collaboration, and innovation, which has consistently translated into strong business performance and growth. Dean b...

Recent research conducted in Italy by Università Cattolica del Sacro Cuore, with support from Barilla Group, has explored the psychological and emotional effects of pasta consumption. The research team led by Professor Francesco Pagnini, a clinical psychologist with previous academic affiliations at Harvard University, investigates the relationship between pasta consumption and emotional well-being. The findings, published in the journal Food Science & Nutrition, suggest that pasta consumpt...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that it has reached a broad reimbursement agreement with NHS England for Vertex’s cystic fibrosis (CF) medicine ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor). This agreement comes as the National Institute for Health and Care Excellence (NICE) has issued a positive final draft recommendation for this medicine. This next-in-class triple combination treatment is licensed for people living with CF aged 6 years and older who ha...